Dysbiotic bacteria drive suppressive neutrophil phenotypes and prolonged lifespan in mucosal tissues of HIV-infected individuals Nichole Klatt AIDS 2016,

Slides:



Advertisements
Similar presentations
HCV cure: new treatment paradigms for HCV infection Sanjay Bhagani Consultant Physician/Senior Lecturer Royal Free Hospital/UCL London.
Advertisements

2014 “Towards an HIV Cure” symposium Melbourne Following in vitro culture with myeloid dendritic cells, negative regulators of T cell activation are expressed.
 Longitudinal analysis of mucosal immune quiescence and impact of commercial sex work in HIV Exposed Seronegative (HESN) sex workers from Nairobi, Kenya.
Comparison between Pathogenic and Nonpathogenic SIV Infections and Focus on Mucosal Tissue Compartment Reveal a Critical Role for the.
Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques Alexandra M. Ortiz Laboratory of Jason Brenchley July 23,
Role of Adaptive vs. Innate Immune Activation in non-AIDS Morbidity Peter W. Hunt, MD Associate Professor of Medicine UCSF HIV/AIDS Division.
“Personalized Medicine, Colorectal Cancer and Gut Bacteria”
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
Slide 1 of 10 From DC Douek, MD, at Atlanta, GA: April 10, 2013, IAS-USA. IAS–USA Daniel C. Douek, MD, PhD Bethesda, Maryland Immune Activation, HIV Persistence,
CD4+ memory stem cells (T SCM ) in pathogenic and non- pathogenic SIV infections Guido Silvestri, MD Yerkes National Primate Research Center Emory University.
Myeloid cells matter Conclusions. Glut1+ CD14++ CD16+ Associated with inflammatory markers HIV Immune activation HIV-related diseases Joshua Anzigen:
2014 “Towards an HIV Cure” Symposium Melbourne IL-21 reduces residual inflammation and virus persistence in ART-treated SIV- infected rhesus macaques Mirko.
The Human Microbiome: PSC, IBD, and the Gut-Liver Axis
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Chapter 10. Cell-mediated immunity (CMI) is the type of host defense that is mediated by T lymphocytes, and it serves as a defense mechanism against.
IAS 2014, Melbourne Mechanisms of non-pathogenicity in HIV- Lessons from paediatric infection.
#AIDS2016 HIV Persists in Colon and Blood CCR6+ T-Cells During Viral Suppressive ART Jean-Pierre Routy on behalf of : A. Gosselin, T.
Probiotics and Prebiotics emerging roles in health Amin Salehi-Abargouei PhD in Nutrition Nutrition and Food Security research Center Shahid Sadoughi.
Functional Microbiomics: Gut Bacteria and the Immune System
Impact of a fat-rich diet on the pathogenesis of SIV infection
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
What’s All the Fuss About the Microbiome?
Global Overview of the Microbiome: Beyond HIV
Innate Immune Response (Ch14)
Mononuclear phagocytes in Immune Defence
Longitudinal changes in airway microbiome signatures and immunoregulatory cell dynamics following Bronchial Thermoplasty Jessy Deshane, Ph.D. Department.
University Hospital Ulm, Germany
An overview of bacterial mechanisms for pathogenicity.
Cancer Immune Therapy and Auto-inflammation in the Gut
Obesity and Cancer: The Oil that Feeds the Flame
Coinfection With HIV-1 and HCV—A One-Two Punch
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Contribution of the gut microbiota
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice by Ramona S. Scotland, Melanie J.
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Gut–liver immunity Journal of Hepatology
The Gastrointestinal Tract and AIDS Pathogenesis
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Figure 2 Type 3 immunity and AS
Figure 2 Microbiota and osteoimmunology
Figure 2 Altered innate immune functions after sepsis
The Intestinal Immune System in Obesity and Insulin Resistance
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
The Origins and Drivers of Insulin Resistance
Bridging immunity and lipid metabolism by gut microbiota
Figure 1 Mucosal immune networks
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Coinfection With HIV-1 and HCV—A One-Two Punch
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Lipid mediators in immune dysfunction after severe inflammation
Role of the Microbiota in Immunity and Inflammation
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Drivers of chronic rhinosinusitis: Inflammation versus infection
Figure 1 Chronic inflammation and DNA damage in people with SLE
The gastrointestinal mucosa in health, CDI, and UC
Figure 2 Lifelong influences on the gut microbiome from
The Gastrointestinal Tumor Microenvironment
Geneva, Switzerland June 2002
Dan R. Littman, Eric G. Pamer  Cell Host & Microbe 
Author Names Interleukin-17 and Gut Microbiota Axis In The Regulation of Metabolic Activities 1Queensborough Community College, 2Molecular Genetics & Microbiology,
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
Publication output between 1970 and 2015 in the field of microbiology and CRS. Data for the number of publications per year were generated by using the.
Chain of events leading to pulmonary immunopathology following HMPV infection. Chain of events leading to pulmonary immunopathology following HMPV infection.
Presentation transcript:

Dysbiotic bacteria drive suppressive neutrophil phenotypes and prolonged lifespan in mucosal tissues of HIV-infected individuals Nichole Klatt AIDS 2016, Drivers of HIV Progression July 19 th, 2016 Durban, South Africa

Inflammation (particularly associated with mucosal dysfunction) is a key predictor of morbidities and mortality

Epithelial Barrier Breaches and Microbial Translocation Estes et al., Plos Pathogens 2010 What are the mechanisms of mucosal dysfunction in HIV Infection? 3

Burgener, McGowan, Klatt; Curr Opinion Immunol 2015

Neutrophils have both phagocytic and suppressive functions Kolaczkowska, et al. Nat. Rev. Immun., 2013; Leliefield et al., Critical Care 2016 Tissue Damage T cell suppression 5 Anti-microbial functions

Neutrophils can be suppressive Neutrophils can be inflammatory

CD15 CD66b CD16 CD11b CD49d SSC-A CD15 CD11b CD66b CD49d CD16 CD49d CD16 SSC-A Neutrophils and Eosinophils Exclude eosinophils GranulocytesNeutrophils eosinophils HIV+ Blood HIV+ GI Neutrophils accumulate in GI tract of HIV-infected individuals What mechanisms underlie this accumulation during HIV infection?

Dysbiosis in HIV infection Zevin, McKinnon, Burgener, Klatt; Curr Opinion HIV/AIDS 2016

Question: Does altered microbiome in HIV infection affect neutrophil populations? Whole blood: 4 HIV- 2 HIV+ Incubate with HAMBs 20 hours Increased in HIV: Prevotella copri Prevotella stercorea Decreased in HIV: Rhumnicoccus bromii Lactobacullus plantarum Controls: No stim (-) Media alone (-) LPS (+) CD11b CD15 SSC-A (CD45+/CD3-/CD20-) Neutrophils PD-L1 CD16 CD62L Arginase-1 “Suppressive” “Phagocytic”

Microbiota increased in HIV induce “suppressive” neutrophil phenotype, but not “normal” neutrophils

Prevotella induce PD-L1 on neutrophils

PD-1 expression correlates with HIV reservoir PD-1 expression correlates with HIV load

Neutrophil PD-L1 expression associated with CD4+ T cell PD-1 expression

Potential mechanism of neutrophil accumulation in GI tract is enhanced survival by dysbiotic bacteria

Conclusions : Neutrophils and HIV Altered Mucosal Bacteria Dysbiotic bacteria induce suppressive phenotype of neutrophils in HIV infection Potential contributions to microbial translocation/inflammation in HIV infection Dysbiotic bacteria promote PD-L1 expression on neutrophils, which may drive CD4 PD-1 Implications for reservoir Dysbiotic bacteria in HIV may promote neutrophil survival, leading to accumulation of neutrophils in the GI tract Potential contribution to mucosal dysfunction

UW/WaNPRC/Pharmaceutics Klatt Lab Tiffany Hensley-McBain Alex Zevin, PhD Ryan Cheu Jennifer Manuzak, PhD Charlene Miller De’Neka Gary Ernesto Coronado Arina Wu Lydia Sweet Kevin Fogassey Toni Gott UC Denver Cara Wilson Steph Dillon Eric Lee Acknowledgements UW Harborview Hospital Ann Collier Michalina Montano Lindsay Legg Jai Lingappa Bob Harrington Northwestern University Tom Hope Michael Dixson University of Manitoba/National Microbiology Laboratory Adam Burgener UCSF SCOPE Peter Hunt NIH/NIAID 1K22AI NIH/NIDA 1DP1DA NIH/NIAID 1R01AI NSF Fellowship (Hensley-McBain) UW CFAR